BioPh China 2018
June 20-22, 2018
A Perfect Blend of
Bio-solutions for Pharma

Shanghai New International Exhibition Center (SNIEC)
  • CPhI China 2017
  • CPhI China 2017
  • CPhI China 2017
  • CPhI China 2014

Ms. Cindy Tan
Tel:+86 (21) 3339 2252
E-mail: cindy.tan@ubmsinoexpo.com

Asia’s Premier Partnering Event to
Meet Global Biopharmaceutical Stakeholders

First launched in 2012, BioPh China has become one of Asia’s top focused exhibitions in the fields of gene engineering, antibody engineering, cell culture, biological Instrument, etc. for people from pharmaceutical or biotech companies, research institutes and all other industry stakeholders to meet, network and discuss latest industry trends, partnership models and investment opportunities together.

BioPh China 2018 will be held on June 20-22, 2018 at Hall W5, Shanghai New International Expo Centre with direct access to pharmaceutical trading & information sharing all in one place.



ProteinDrug Research & DevelopmentBiotechnology
AntigenTherapeuticsDiagnostic Reagents
AntibodiesBio-manufacturingBiological Engineering
VaccinesCell BiologyNanotechnology
PolypeptideClinical TrialsBioanalysis
Enzyme Genomic / GeneticsBiofuels
BioprocessingPersonalized MedicineBioinformatics
BiologicsStem Cell ResearchDatabase Management



"BioPh China created great business opportunities for us. We developed many new clients on site of the show.

——International Business, Gene Science Pharmaceuticals"

"I really enjoyed to exhibit on BioPh China! It is a nice platform to meet decision makers from worldwide biopharmaceutical companies."

——Marketing, Shenzhen Mellow Hope Pharm Industrial


4th China BioPh Outlook Summit
- June 20-21, 2017
This two-day summit invited over 20 senior executives from such pharmaceutical companies as Bristol-Myers Squibb, Novartis, GSK, WuXi Biologics, Innovent Biologics and Shanghai ChemPartner. They, together with over 120 elites from domestic and foreign pharmaceutical and biotechnology companies, discussed the future of biopharma with focus on four areas: pharmaceutical markets, precision medicine, protein and peptide drugs, antibody drugs R&D.
CPhI CRO & CMO Forum
- June 20, 2017
As R&D cost of pharmaceutical companies has increasingly risen, big pharma companies have outsourced more and more drug R&D and production to CRO and CMO. The presence of professional CRO & CMO and their specific technology advantage have become the most important link in the ecosystem of new drug R&D. This year we invited CRO & CMO specialists from Patheon, PharmaBlock Sciences, Shanghai RUNDO, Beijing Clinical Service Center and WuXi AppTec, as well as specialists in purchasing and supply chain departments of pharma companies like Johnson & Johnson, Roche and Agios, to discuss how pharmaceutical companies and CRO/CMO achieve win-win cooperation.
CPhI R & D Day
Specific R&D Visitor Route
Since CPhI R&D Day was introduced in 2015, there have been over 3,700 pharma R&D staff joined the activity. In 2017, the organizer planned a special R&D Day again during the show. It tailored R&D Visitor Route for biopharma R&D visitors. Moreover, the exclusive R&D Day Map was available on the spot, which helped to display R&D information more directly to the visitors, so that visitors' show experience was further improved.


CPhI.cn——China's leading B2B Marketplace for Pharmaceutical IndustryWechat——Mobile Marketing Promotions
Email Blasting——More Than 6,949,673 Emails Sent to Professional Data Base Direct Mailing——More Than 552,206 Mails Directly Sent to Industry Players
Weibo——Weibo.com/cphi Interactive Activities though Instant Info SharingConferences——Best Practices Sharing & Case Studies Brainstorming
Media——Cooperation with Worldwide Authoritative Media